Latest Articles
- Biological and chemical terrorism: Recognition and management
Future terrorist attacks might involve a variety of chemical or biological agents, including nerve agents, blistering agents, hydrogen cyanide, ricin, anthrax, smallpox, plague, and botulinum toxin. Physicians are on the front line.
- When should central venous catheters be changed in the intensive care unit? Should there be a rigid time-based protocol for doing so?
The decision is made case by case rather than on a time-based protocol. Proactive strategies can reduce the risk of infection.
- Cox - 2 Inhibitors and Cardiovascular Risk
Unless a clear cause-and-effect relationship can be proved between COX-2 inhibitors and cardiovascular events, we should go on using these drugs.
- Cox - 2 Inhibitors and Cardiovascular Risk
Even if we do not know with certainty whether COX-2 inhibitors increase the risk of cardiovascular events, we need to incorporate this concern into our practice.
- How often are atrial septal defects associated with thromboembolism? When should they be looked for?
In the absence of other causative conditions, an atrial septal defect may be presumed to be the underlying cause of a stroke, especially in younger patients.
- Cox - 2 Inhibitors and Cardiovascular Risk
Our study had limitations, but we believe our hypothesis is plausible, our methods were valid, and our conclusions are sound.
- Recognizing and treating diabetic autonomic neuropathy
Strict glycemic control can slow the onset of diabetic autonomic neuropathy and sometimes reverse it. Other treatments address specific symptoms.
- Chronic myelogenous leukemia: The news you have and haven’t heard
One major advance in treating CML was widely publicized. Another, although equally important, was not.
- COX-2 inhibitors: Balancing the hope, the hype, and the concern
When all is said and done, the choice rests with the individual prescribing physician.